Article · 13 Feb 2026
Conference abstractPublished 23 Nov 2012
Role of value chain in easing regulatory processes and approvals for herbal products
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The WHO has estimated the demand for medicinal plants is approximately $14 Billion per annum (2006). The demand is growing at the rate of 15 to 25% annually and by 2050 trade will be up to US$ 5 Trillion. Yet the herbal industry is still disorganized and relies heavily on the wild collection of raw material. There is inconsistency in quality, content and therapeutic value. Standardization of raw materials collected from wild sources poses a daunting task as it involves several layers of collectors, handlers and commission agents. Considerable measure of standardization and organization can be introduced to this ill-organized sector by adopting a structured value chain that ensures adequate returns for every stakeholder: From farmer/collector to service personnel. Though value chains are the fulcrum of several advanced enterprises like the food industry, this concept has completely by-passed the Herbal industry. Few manufacturers have explored the urgent need for fool-proof value chains of herbal medicines and derivative products. NGOs or governmental studies identified have confined themselves to achieving sustainable livelihoods in small pockets with maximum sociological, ecological and economic impact. There are crucial gaps in medicinal plant research, raw material standardization and studies on drug interactions in polyherbal products which impact acceptability of Indian herbal products in the global arena. Establishing a well defined value chain for the herbal segment can ensure increased accountability, quality, profitability, and fair trade, safe and smooth supply of herbal medicines. A thorough technical and economic feasibility study of the value chain, long term involvement, familiarity of the diverse agro climatic zones and a deep understanding of the prevalent farming systems are required to ensure the success of the chain. The ultimate proof of success of the chain that truly creates shared value lies in establishing various systems, processes and limits acceptable to the most stringent of regulatory authorities across the world: After all, the herbal industry revolves around the betterment of human and animal lives and no compromises are permitted.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Suma Krishnaswamy”
